StockWatch
·

HMA Agro Industries Ltd Q2 FY27 Results

HMAAGROQ2 FY27 Results
Filing
Result:Steady· Market: Flat#Base effect#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.8K31.7%29.0%
Total Income2.8K29.0%28.4%
Expenditure2.7K26.5%29.3%
PBT132.48111.9%13.2%
Net Profit104.57107.0%16.5%
OPM4.28%3.84pp0.15pp
NPM3.72%1.41pp0.38pp
EPS2.08105.9%16.2%
View full financials

Revenue/PAT grew but core OPM/NPM compressed YoY (4.28% vs 4.43%, 3.72% vs 4.10%) on higher finance costs and a weaker subsidiary contribution, so this is in-line agri-processing growth rather than a standout.

HMA AGRO · Q2 FY27 · THE VERDICT

Revenue Surged 29%, But Margins Stalled — Management's Recovery Promise Hangs on External Factors

HMA delivered strong 29% YoY revenue growth and entered a 49th country, but profit margins compressed 41 basis points despite the top-line surge. Management pins a 1.5–2% margin recovery on logistics normalization—a bet worth watching closely.

06 Nov 2026 · 6 min read
Q2 Revenue

₹2,779.5 Cr

+29% YoY

Q2 PAT

₹104.6 Cr

+16.5% YoY

PAT margin

3.76%

−41 bps YoY

EBITDA margin

5.25%

−85 bps YoY

HMA's Q2 revenue story looks clean at first glance: 29% YoY growth to ₹2,779.5 crore, accelerating to 31.7% sequentially from Q1's ₹2,110 crore. PAT rose 16.5% to ₹104.6 crore, and on a quarterly basis nearly doubled from Q1's ₹50.5 crore. The export footprint now spans 49 countries across four continents. But zoom into the margin line, and the picture inverts: profit margins compressed 41 basis points YoY to 3.76%, with EBITDA margins falling 85 bps to 5.25%. Revenue grew, but profitability lagged—that gap is the quarter.

The logistics squeeze

Management was candid on the call: elevated logistics and trade costs squeezed margins despite strong pricing power. CFO Gulzeb Ahmed stated logistics 'already reached its peak' and anchored the margin recovery assumption to a normalization of shipping freight. The company generated strong top-line momentum—both volume and value contributed to the 29% revenue growth—but could not pass through the full freight headwind to customers, who have already absorbed prior price moves. The math: EBITDA margin fell 85 bps while revenue surged 29%, meaning cost of goods and operating expenses rose faster than sales.

YoY change, basis points
-98.68-51.56-4.4442.68-41PAT margin-85EBITDA margin29Revenue growth
Margins compressed despite strong revenue growth. Cost inflation (logistics, trade) outpaced price realization in Q2 FY27 vs Q2 FY26.
Logistics prices have already reached to its peak. Once geopolitical tensions ease, expect to secure half of prior shipping costs, pulling 1.5–2% margin improvement.

What management claims—and what holds up

Management's key assertions vs. delivered reality

Strong growth momentum via multi-buyer, multi-country export strategy

Q2 revenue ₹2,779.5 Cr, +29% YoY, +31.7% QoQ. H1 revenue up 49.2% YoY to ₹4,889.8 Cr.

Supported

Logistics costs at peak; expect 1.5–2% margin recovery if costs normalize

Margin compression of 41 bps YoY is real. Recovery forecast is forward-looking, contingent on external freight normalization, no timeline specified.

Slightly overstated

Company operates at 65–70% capacity utilization with no capex need

Consistent with disclosed utilization. Working capital only if orders increase; no major capex flagged.

Supported

Export reach to 49 countries across 4 continents with diversification

Not contradicted by results. Footprint disclosed but granular segment data by geography absent.

Supported

Indian products 65–70% cheaper than Australian/Brazilian equivalents

Positioning claim not verifiable from financials. Structural cost advantage is plausible given India's agricultural economy.

Supported (as positioning)

What changed on this call

How the street is positioned

HMA trades at ₹27.3, well above its 20-, 50-, and 200-day moving averages (₹24.7, ₹23.3, ₹23.7 respectively), suggesting technical momentum. The stock has recovered 43% from its 52-week low of ₹19.09—a meaningful rebound. However, it remains 67.5% below its all-time high of ₹84.05, a reminder of the sharp drawdown from peak valuation. Volume is trending upward, consistent with the recovery. RSI at 65.5 sits in neutral territory, not yet overbought.

On the ownership front, the latest quarter (Q1 FY27) shows FII stake at 4.83%, down slightly 0.04pp sequentially, while domestic institutional ownership (DII) rose 2.05pp to 3.46%. Promoter stake declined 6.63pp to 75%, suggesting some promoter trimming alongside the FII exit. The mixed signal: International institutions are edging out, but domestic investors are adding. This positioning may reflect caution on margin recovery timing paired with domestic confidence in the logistics-driven recovery thesis.

The bull-bear ledger

  • Exceeded prior ₹1 billion FY26 revenue target; now at ~₹5.5 billion annualized run-rate

  • 29% YoY revenue growth corroborates multi-geography export strategy

  • 49-country footprint across four continents provides geographic diversification

  • 65–70% capacity utilization enables volume scaling without major capex

  • Margin compression of 41 bps YoY despite 29% revenue growth signals cost pressure

  • 1.5–2% margin recovery forecast lacks timeline and is contingent on external logistics normalization

  • New product categories (seafood, rice, chilled meat) acknowledged as early-stage; execution risk on scaling

  • Customer concentration not disclosed; 49-country footprint suggests some diversification but major buyer dependency unknown

  • Geopolitical food security tailwind may be cyclical; demand could moderate if tensions ease

  • FII trimming while promoter reducing stake; domestic buying not fully offsetting international exit

Risks ranked—by how much they should concern a holder

Margin recovery dependent on external logistics normalization

Medium–High

41 bps margin compression is material. Recovery forecast (1.5–2%) is forward-looking and contingent on geopolitical de-escalation and shipping freight decline—both uncertain near-term. No quarterly targets or timeline provided.

Geopolitical food security demand cyclicality

Medium

Management acknowledged growth partly driven by countries stockpiling food due to global tensions. If geopolitical tensions ease, buying pattern may normalize, impacting revenue trajectory and the case for sustained 25–30% growth.

Margin recovery forecast vague—no timeline or quarterly targets

Medium

CFO qualified recovery with language like 'hope' and 'chances' rather than assertive guidance. No specific quarter or margin target provided. Market may reprice if recovery extends beyond Q3–Q4.

New product portfolio concentration and execution risk

Low–Medium

Seafood, rice, and chilled meat acknowledged as early-stage. Revenue contribution not quantified. If core buffalo meat demand softens, immature new categories cannot offset quickly.

Customer concentration not disclosed

Low

49-country footprint suggests geographic diversification, but specific customer names or concentration % not provided. Major buyer dependency could cap upside or create volatility.

FII outflow and promoter stake reduction

Low–Medium

International investors trimming (−0.04pp), and promoter declining 6.63pp suggests uncertainty on recovery thesis. If FII exit accelerates, liquidity and valuation support could weaken.

The debate

What to watch next

  • 1 · Q3 EBITDA and PAT margin—the acid test

    Is logistics cost normalization visible in the margin line? Management targets 1.5–2% recovery; Q3 should show at least 50–75 bps of the promised improvement if the thesis holds. Any further compression invalidates the recovery narrative.

  • 2 · FTA completion timeline—Europe and GCC market access

    Management cited potential new market access if India-Europe and India-GCC free trade agreements close. Timing and quantified revenue upside are not yet disclosed. Any FTA breakthrough could unlock a new growth leg.

  • 3 · New product category revenue contribution—seafood, rice, chilled meat

    Acknowledged as early-stage on the call. Q3 or Q4 should provide quantified revenue split by category. If new product revenue contribution accelerates to 10–15% of total, it shifts the growth narrative beyond geopolitical cyclicality.

  • 4 · Management cost-structure transparency

    CFO deferred on NOP (Net Operating Profit) % metrics and agreed to email response post-call. If detailed cost breakdown surfaces in subsequent quarterly reports, it will clarify whether margin recovery is attainable or dependent on heroic logistics assumptions.

HMA's Q2 is a story of strong execution on revenue growth paired with margin pressure from external headwinds. The company has proven it can scale exports, diversify geographically, and grow PAT in absolute terms. But it has not yet proven it can expand margins while the sector faces logistics inflation. Management's 1.5–2% recovery forecast is plausible, given logistics are described as at a peak; however, without a timeline or quarterly commitment, it remains aspirational rather than guidance.

The stock has recovered well from its lows and sits above key moving averages, suggesting momentum. However, domestic institutional appetite (rising DII) and international caution (declining FII, promoter trimming) signal the market is waiting for proof of margin recovery before committing fresh capital. Hold the position pending Q3 margin data. The single number to track from here is EBITDA margin—a return to 5.8–6.0% would validate the recovery thesis and justify a re-rating; any stagnation at 5.2–5.5% would suggest logistics headwinds are proving stickier than management predicted.

Informational and educational content only. Not investment advice.